Please fill out the form to inquire about our business relations.
| TRANSACTIONS |
A full record of our completed mandates and active engagements across energy transition, life sciences, and advanced technology sectors.
DATE
STATUS
TRANSACTION
VALUE
—
Completed
Capital raise for CH4 Global — Series B, Climate Technology
USD 45,000,000
—
Completed
Capital raise for Clarametyx Biosciences — Series A, Therapeutics
USD 33,000,000
—
Completed
Capital raise for Remedium — Series A, Gene Therapy
USD 15,000,000
—
Completed
Capital raise for DayZero Diagnostics — Series A, Diagnostics
USD 21,000,000
—
Completed
Capital raise for Travera — Series A, Precision Medicine
USD 7,000,000
—
Completed
Capital raise for Regencor — Series A, Regenerative Medicine
Undisclosed
—
Completed
Capital raise for PineTree Therapeutics — Series A2, Therapeutics
Undisclosed
—
Completed
Capital raise for Bantam Pharmaceutical — Series A, Therapeutics
Undisclosed
—
Completed
Seed round capital raise for Juniper Genomics — Genomic Testing
USD 2,700,000
—
Completed
Capital raise for BioEclipse Therapeutics — Series B, Therapeutics
Undisclosed
—
Completed
Capital raise for CoaStar Therapeutics — Series A Extension, Therapeutics
USD 4,500,000
—
Completed
Capital raise for Navan — Series A, Therapeutics
USD 5,000,000
—
Completed
Advising on Series A investment in Ochrebio — Therapeutics
USD 34,000,000
—
Completed
Asset valuation advisory — Metabolic Disease Therapeutics
N/A
—
Completed
Asset valuation advisory — CNS Disease Therapeutics
N/A